{"transactions":[{"id":724659,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-06-29T22:00:05.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":11421,"price":26.0846,"value":297912.2166,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.88 to $26.265, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":13088,"source":{"system":"sec-edgar","filing":"0001816160-26-000009","document":"form4-06292026_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000009/form4-06292026_060601.xml","form_type":"4"}},{"id":762503,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-05-27T22:00:05.000Z","date":"2026-05-26","kind":"sale","planned":false,"acquired":false,"shares":5401,"price":21.18,"value":114393.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.1801 to $21.185, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 781 shares of the Issuer's common stock acquired by the reporting person on May 15, 2026 pursuant to an employee stock purchase plan."}],"balance_after":24509,"source":{"system":"sec-edgar","filing":"0001816160-26-000008","document":"form4-05272026_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000008/form4-05272026_060501.xml","form_type":"4"}},{"id":792572,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-05-05T22:00:19.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":2596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":2596,"derivative":{"underlying":"Common Stock","underlying_shares":2596},"source":{"system":"sec-edgar","filing":"0001816160-26-000007","document":"form4-05052026_060511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000007/form4-05052026_060511.xml","form_type":"4"}},{"id":792571,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-05-05T22:00:19.000Z","date":"2026-05-04","kind":"sale","planned":false,"acquired":false,"shares":1332,"price":21.79,"value":29024.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.79 to $21.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":29129,"source":{"system":"sec-edgar","filing":"0001816160-26-000007","document":"form4-05052026_060511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000007/form4-05052026_060511.xml","form_type":"4"}},{"id":792570,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-05-05T22:00:19.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":2596,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":30461,"source":{"system":"sec-edgar","filing":"0001816160-26-000007","document":"form4-05052026_060511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000007/form4-05052026_060511.xml","form_type":"4"}},{"id":813765,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-04-07T23:55:40.000Z","date":"2026-04-05","kind":"exercise","planned":false,"acquired":false,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2010},"source":{"system":"sec-edgar","filing":"0001816160-26-000005","document":"form4-04072026_110435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000005/form4-04072026_110435.xml","form_type":"4"}},{"id":813764,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-04-07T23:55:40.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":1030,"price":22.2,"value":22866.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.07 to $22.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":27865,"source":{"system":"sec-edgar","filing":"0001816160-26-000005","document":"form4-04072026_110435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000005/form4-04072026_110435.xml","form_type":"4"}},{"id":813763,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-04-07T23:55:40.000Z","date":"2026-04-05","kind":"exercise","planned":false,"acquired":true,"shares":2010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":28895,"source":{"system":"sec-edgar","filing":"0001816160-26-000005","document":"form4-04072026_110435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000005/form4-04072026_110435.xml","form_type":"4"}},{"id":827621,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-27T00:00:08.000Z","date":"2026-03-25","kind":"exercise","planned":false,"acquired":false,"shares":2142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."}],"balance_after":4284,"derivative":{"underlying":"Common Stock","underlying_shares":2142},"source":{"system":"sec-edgar","filing":"0001816160-26-000003","document":"form4-03262026_080304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000003/form4-03262026_080304.xml","form_type":"4"}},{"id":827620,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-27T00:00:08.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":1627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":4883,"derivative":{"underlying":"Common Stock","underlying_shares":1627},"source":{"system":"sec-edgar","filing":"0001816160-26-000003","document":"form4-03262026_080304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000003/form4-03262026_080304.xml","form_type":"4"}},{"id":827619,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:08.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":12,"price":21.7253,"value":260.7036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":26885,"source":{"system":"sec-edgar","filing":"0001816160-26-000003","document":"form4-03262026_080304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000003/form4-03262026_080304.xml","form_type":"4"}},{"id":827618,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:08.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":1097,"price":21.65,"value":23750.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":26897,"source":{"system":"sec-edgar","filing":"0001816160-26-000003","document":"form4-03262026_080304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000003/form4-03262026_080304.xml","form_type":"4"}},{"id":827617,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:08.000Z","date":"2026-03-25","kind":"exercise","planned":false,"acquired":true,"shares":2142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":27994,"source":{"system":"sec-edgar","filing":"0001816160-26-000003","document":"form4-03262026_080304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000003/form4-03262026_080304.xml","form_type":"4"}},{"id":827616,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:08.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":833,"price":21.47,"value":17884.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":25852,"source":{"system":"sec-edgar","filing":"0001816160-26-000003","document":"form4-03262026_080304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000003/form4-03262026_080304.xml","form_type":"4"}},{"id":827615,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:08.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":1627,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":26685,"source":{"system":"sec-edgar","filing":"0001816160-26-000003","document":"form4-03262026_080304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000003/form4-03262026_080304.xml","form_type":"4"}},{"id":851812,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T22:00:18.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":6332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."}],"balance_after":6332,"derivative":{"underlying":"Common Stock","underlying_shares":6332},"source":{"system":"sec-edgar","filing":"0001816160-26-000002","document":"form4-03102026_060314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000002/form4-03102026_060314.xml","form_type":"4"}},{"id":851811,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-10T22:00:18.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":21766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":21766,"derivative":{"exercise_price":22.16,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":21766},"source":{"system":"sec-edgar","filing":"0001816160-26-000002","document":"form4-03102026_060314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616026000002/form4-03102026_060314.xml","form_type":"4"}},{"id":994401,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-11-19T23:00:05.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":false,"shares":3966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3966},"source":{"system":"sec-edgar","filing":"0001816160-25-000004","document":"form4-11192025_061101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616025000004/form4-11192025_061101.xml","form_type":"4"}},{"id":994400,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-11-19T23:00:05.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":false,"shares":3966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3966},"source":{"system":"sec-edgar","filing":"0001816160-25-000004","document":"form4-11192025_061101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616025000004/form4-11192025_061101.xml","form_type":"4"}},{"id":994399,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-11-19T23:00:05.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":4084,"price":23.6909,"value":96753.6356,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.69 to $23.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":25058,"source":{"system":"sec-edgar","filing":"0001816160-25-000004","document":"form4-11192025_061101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616025000004/form4-11192025_061101.xml","form_type":"4"}},{"id":994398,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-11-19T23:00:05.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":true,"shares":3966,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":29142,"source":{"system":"sec-edgar","filing":"0001816160-25-000004","document":"form4-11192025_061101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616025000004/form4-11192025_061101.xml","form_type":"4"}},{"id":994397,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-11-19T23:00:05.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":true,"shares":3966,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 815 shares of the Issuer's common stock acquired by the reporting person on November 14, 2025 pursuant to an employee stock purchase plan."}],"balance_after":25176,"source":{"system":"sec-edgar","filing":"0001816160-25-000004","document":"form4-11192025_061101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181616025000004/form4-11192025_061101.xml","form_type":"4"}},{"id":1143611,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-05-20T00:52:56.000Z","date":"2025-05-16","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":20,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024."}],"balance_after":20395,"source":{"system":"sec-edgar","filing":"0001415889-25-013742","document":"form4-05202025_120553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925013742/form4-05202025_120553.xml","form_type":"4"}},{"id":1143610,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-05-20T00:52:56.000Z","date":"2025-05-16","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":25,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 869 shares of the Issuer's common stock acquired by the Reporting Person on May 15, 2025 pursuant to an employee stock purchase plan."}],"balance_after":22395,"source":{"system":"sec-edgar","filing":"0001415889-25-013742","document":"form4-05202025_120553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925013742/form4-05202025_120553.xml","form_type":"4"}},{"id":1161637,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-05-03T00:00:34.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":2596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":5192,"derivative":{"underlying":"Common Stock","underlying_shares":2596},"source":{"system":"sec-edgar","filing":"0001415889-25-011875","document":"form4-05032025_120531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925011875/form4-05032025_120531.xml","form_type":"4"}},{"id":1161636,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-05-03T00:00:34.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":1327,"price":14.6,"value":19374.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":23526,"source":{"system":"sec-edgar","filing":"0001415889-25-011875","document":"form4-05032025_120531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925011875/form4-05032025_120531.xml","form_type":"4"}},{"id":1161635,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-05-03T00:00:34.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":2596,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":24853,"source":{"system":"sec-edgar","filing":"0001415889-25-011875","document":"form4-05032025_120531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925011875/form4-05032025_120531.xml","form_type":"4"}},{"id":1175967,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-08T23:38:59.000Z","date":"2025-04-05","kind":"exercise","planned":false,"acquired":false,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":2010,"derivative":{"underlying":"Common Stock","underlying_shares":2010},"source":{"system":"sec-edgar","filing":"0001415889-25-010423","document":"form4-04082025_110455.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925010423/form4-04082025_110455.xml","form_type":"4"}},{"id":1175966,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-04-08T23:38:59.000Z","date":"2025-04-08","kind":"sale","planned":false,"acquired":false,"shares":1028,"price":14.82,"value":15234.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":22257,"source":{"system":"sec-edgar","filing":"0001415889-25-010423","document":"form4-04082025_110455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925010423/form4-04082025_110455.xml","form_type":"4"}},{"id":1175965,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-04-08T23:38:59.000Z","date":"2025-04-05","kind":"exercise","planned":false,"acquired":true,"shares":2010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":23285,"source":{"system":"sec-edgar","filing":"0001415889-25-010423","document":"form4-04082025_110455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925010423/form4-04082025_110455.xml","form_type":"4"}},{"id":1191460,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-03-27T00:10:01.000Z","date":"2025-03-25","kind":"exercise","planned":false,"acquired":false,"shares":2142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."}],"balance_after":6426,"derivative":{"underlying":"Common Stock","underlying_shares":2142},"source":{"system":"sec-edgar","filing":"0001415889-25-009075","document":"form4-03272025_120357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009075/form4-03272025_120357.xml","form_type":"4"}},{"id":1191459,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-03-27T00:10:01.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":6510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":6510,"derivative":{"underlying":"Common Stock","underlying_shares":6510},"source":{"system":"sec-edgar","filing":"0001415889-25-009075","document":"form4-03272025_120357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009075/form4-03272025_120357.xml","form_type":"4"}},{"id":1191458,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-27T00:10:01.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":22152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":22152,"derivative":{"exercise_price":17.23,"expiration_date":"2035-03-23","underlying":"Common Stock","underlying_shares":22152},"source":{"system":"sec-edgar","filing":"0001415889-25-009075","document":"form4-03272025_120357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009075/form4-03272025_120357.xml","form_type":"4"}},{"id":1191457,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-27T00:10:01.000Z","date":"2025-03-26","kind":"sale","planned":false,"acquired":false,"shares":1095,"price":17.05,"value":18669.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":21275,"source":{"system":"sec-edgar","filing":"0001415889-25-009075","document":"form4-03272025_120357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009075/form4-03272025_120357.xml","form_type":"4"}},{"id":1191456,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-27T00:10:01.000Z","date":"2025-03-25","kind":"exercise","planned":false,"acquired":true,"shares":2142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":22370,"source":{"system":"sec-edgar","filing":"0001415889-25-009075","document":"form4-03272025_120357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009075/form4-03272025_120357.xml","form_type":"4"}},{"id":1247365,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-02-25T23:48:49.000Z","date":"2025-02-23","kind":"exercise","planned":false,"acquired":false,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001415889-25-005575","document":"form4-02252025_110245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925005575/form4-02252025_110245.xml","form_type":"4"}},{"id":1247364,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:48:49.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":475,"price":19.96,"value":9481.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":20228,"source":{"system":"sec-edgar","filing":"0001415889-25-005575","document":"form4-02252025_110245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925005575/form4-02252025_110245.xml","form_type":"4"}},{"id":1247363,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:48:49.000Z","date":"2025-02-23","kind":"exercise","planned":false,"acquired":true,"shares":840,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":20703,"source":{"system":"sec-edgar","filing":"0001415889-25-005575","document":"form4-02252025_110245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925005575/form4-02252025_110245.xml","form_type":"4"}},{"id":1359993,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-11-20T01:41:52.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":false,"shares":3965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":3966,"derivative":{"underlying":"Common Stock","underlying_shares":3965},"source":{"system":"sec-edgar","filing":"0001415889-24-027293","document":"form4-11202024_011147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027293/form4-11202024_011147.xml","form_type":"4"}},{"id":1359992,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-11-20T01:41:52.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":false,"shares":3965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":3966,"derivative":{"underlying":"Common Stock","underlying_shares":3965},"source":{"system":"sec-edgar","filing":"0001415889-24-027293","document":"form4-11202024_011147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027293/form4-11202024_011147.xml","form_type":"4"}},{"id":1359991,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-11-20T01:41:52.000Z","date":"2024-11-19","kind":"sale","planned":false,"acquired":false,"shares":4073,"price":16.81,"value":68467.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.768 to $16.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":19863,"source":{"system":"sec-edgar","filing":"0001415889-24-027293","document":"form4-11202024_011147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027293/form4-11202024_011147.xml","form_type":"4"}},{"id":1359990,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-11-20T01:41:52.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":true,"shares":3965,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":23936,"source":{"system":"sec-edgar","filing":"0001415889-24-027293","document":"form4-11202024_011147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027293/form4-11202024_011147.xml","form_type":"4"}},{"id":1359989,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-11-20T01:41:52.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":true,"shares":3965,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 836 shares and 800 shares of the Issuer's common stock acquired by the reporting person on May 15, 2024 and November 15, 2024, respectively, pursuant to an employee stock purchase plan."}],"balance_after":19971,"source":{"system":"sec-edgar","filing":"0001415889-24-027293","document":"form4-11202024_011147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027293/form4-11202024_011147.xml","form_type":"4"}},{"id":1529061,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:00:40.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":2596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":7788,"derivative":{"underlying":"Common Stock","underlying_shares":2596},"source":{"system":"sec-edgar","filing":"0001415889-24-012236","document":"form4-05032024_060507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012236/form4-05032024_060507.xml","form_type":"4"}},{"id":1529060,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:40.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":1326,"price":16.94,"value":22462.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.94 to $17.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":14370,"source":{"system":"sec-edgar","filing":"0001415889-24-012236","document":"form4-05032024_060507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012236/form4-05032024_060507.xml","form_type":"4"}},{"id":1529059,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:40.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":2596,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":15696,"source":{"system":"sec-edgar","filing":"0001415889-24-012236","document":"form4-05032024_060507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012236/form4-05032024_060507.xml","form_type":"4"}},{"id":1544767,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-04-09T22:00:12.000Z","date":"2024-04-07","kind":"exercise","planned":false,"acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0001415889-24-010602","document":"form4-04092024_060403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010602/form4-04092024_060403.xml","form_type":"4"}},{"id":1544766,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-04-09T22:00:12.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":false,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":4020,"derivative":{"underlying":"Common Stock","underlying_shares":2010},"source":{"system":"sec-edgar","filing":"0001415889-24-010602","document":"form4-04092024_060403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010602/form4-04092024_060403.xml","form_type":"4"}},{"id":1544765,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:12.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":762,"price":17.87,"value":13616.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.7267 to $17.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":13100,"source":{"system":"sec-edgar","filing":"0001415889-24-010602","document":"form4-04092024_060403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010602/form4-04092024_060403.xml","form_type":"4"}},{"id":1544764,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:12.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":1028,"price":17.87,"value":18370.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.763 to $17.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":13862,"source":{"system":"sec-edgar","filing":"0001415889-24-010602","document":"form4-04092024_060403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010602/form4-04092024_060403.xml","form_type":"4"}},{"id":1544763,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:12.000Z","date":"2024-04-07","kind":"exercise","planned":false,"acquired":true,"shares":1489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":14890,"source":{"system":"sec-edgar","filing":"0001415889-24-010602","document":"form4-04092024_060403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010602/form4-04092024_060403.xml","form_type":"4"}},{"id":1544762,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:12.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":true,"shares":2010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":13401,"source":{"system":"sec-edgar","filing":"0001415889-24-010602","document":"form4-04092024_060403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010602/form4-04092024_060403.xml","form_type":"4"}},{"id":1559842,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-03-28T00:02:14.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":8568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."}],"balance_after":8568,"derivative":{"underlying":"Common Stock","underlying_shares":8568},"source":{"system":"sec-edgar","filing":"0001415889-24-009273","document":"form4-03282024_120355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009273/form4-03282024_120355.xml","form_type":"4"}},{"id":1559841,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-28T00:02:14.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":13964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":13964,"derivative":{"exercise_price":17.84,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":13964},"source":{"system":"sec-edgar","filing":"0001415889-24-009273","document":"form4-03282024_120355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009273/form4-03282024_120355.xml","form_type":"4"}},{"id":1616811,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-02-27T23:07:09.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":false,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":840,"derivative":{"underlying":"Common Stock","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001415889-24-005574","document":"form4-02272024_110201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005574/form4-02272024_110201.xml","form_type":"4"}},{"id":1616810,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T23:07:09.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":474,"price":24.67,"value":11693.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":11391,"source":{"system":"sec-edgar","filing":"0001415889-24-005574","document":"form4-02272024_110201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005574/form4-02272024_110201.xml","form_type":"4"}},{"id":1616809,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRINCIPAL ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T23:07:09.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":true,"shares":840,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":11865,"source":{"system":"sec-edgar","filing":"0001415889-24-005574","document":"form4-02272024_110201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005574/form4-02272024_110201.xml","form_type":"4"}},{"id":1710021,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-12-16T00:37:07.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":28.3,"value":56600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."}],"balance_after":11025,"source":{"system":"sec-edgar","filing":"0001209191-23-058891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123058891/doc4.xml","form_type":"4"}},{"id":1733260,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-21T23:00:14.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":false,"shares":1982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":7931,"derivative":{"underlying":"Common Stock","underlying_shares":1982},"source":{"system":"sec-edgar","filing":"0001209191-23-056354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056354/doc4.xml","form_type":"4"}},{"id":1733259,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-21T23:00:14.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":false,"shares":1982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":7931,"derivative":{"underlying":"Common Stock","underlying_shares":1982},"source":{"system":"sec-edgar","filing":"0001209191-23-056354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056354/doc4.xml","form_type":"4"}},{"id":1733258,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:14.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":1985,"price":22.64,"value":44940.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.615 to $22.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":13025,"source":{"system":"sec-edgar","filing":"0001209191-23-056354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056354/doc4.xml","form_type":"4"}},{"id":1733257,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:14.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":true,"shares":1982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":15010,"source":{"system":"sec-edgar","filing":"0001209191-23-056354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056354/doc4.xml","form_type":"4"}},{"id":1733256,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:14.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":true,"shares":1982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 268 shares of the Issuer's common stock acquired by the reporting person on November 15, 2023 pursuant to an employee stock purchase program."}],"balance_after":13028,"source":{"system":"sec-edgar","filing":"0001209191-23-056354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056354/doc4.xml","form_type":"4"}},{"id":1777980,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-19T22:31:39.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":25.88,"value":51760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 3,611 shares acquired by the Reporting Person under the Issuer's 2004 Employee Stock Purchase Plan on November 13, 2020, May 14, 2021, November 15, 2021, May 13, 2022, November 15, 2022 and May 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 23 shares purchased by the Reporting Person in open market transaction on November 21, 2020, with a purchase price of $43.01 per share."}],"balance_after":10778,"source":{"system":"sec-edgar","filing":"0001209191-23-050072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123050072/doc4.xml","form_type":"4"}},{"id":1853025,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-06-16T20:38:53.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":24.15,"value":48300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."}],"balance_after":9144,"source":{"system":"sec-edgar","filing":"0001209191-23-037932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123037932/doc4.xml","form_type":"4"}},{"id":1885491,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T22:54:07.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":5947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":9913,"derivative":{"underlying":"Common Stock","underlying_shares":5947},"source":{"system":"sec-edgar","filing":"0001209191-23-031245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031245/doc4.xml","form_type":"4"}},{"id":1885490,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T22:54:07.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":5947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":9913,"derivative":{"underlying":"Common Stock","underlying_shares":5947},"source":{"system":"sec-edgar","filing":"0001209191-23-031245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031245/doc4.xml","form_type":"4"}},{"id":1885489,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-05-19T22:54:07.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":5947,"price":22.5,"value":133807.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":11144,"source":{"system":"sec-edgar","filing":"0001209191-23-031245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031245/doc4.xml","form_type":"4"}},{"id":1885488,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-05-19T22:54:07.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":5947,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":17091,"source":{"system":"sec-edgar","filing":"0001209191-23-031245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031245/doc4.xml","form_type":"4"}},{"id":1885487,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-05-19T22:54:07.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":5947,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":11144,"source":{"system":"sec-edgar","filing":"0001209191-23-031245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031245/doc4.xml","form_type":"4"}},{"id":1906749,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-04T01:13:08.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":10384,"derivative":{"underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-23-027203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027203/doc4.xml","form_type":"4"}},{"id":1906748,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-04T01:13:08.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":17131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on May 1, 2024. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":17131,"derivative":{"exercise_price":21.75,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":17131},"source":{"system":"sec-edgar","filing":"0001209191-23-027203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027203/doc4.xml","form_type":"4"}},{"id":1921927,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-12T01:15:57.000Z","date":"2023-04-07","kind":"exercise","planned":false,"acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024."}],"balance_after":1489,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0001209191-23-024061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123024061/doc4.xml","form_type":"4"}},{"id":1921926,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-12T01:15:57.000Z","date":"2023-04-10","kind":"sale","planned":false,"acquired":false,"shares":523,"price":18.14,"value":9487.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.14 to $18.165, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5197,"source":{"system":"sec-edgar","filing":"0001209191-23-024061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123024061/doc4.xml","form_type":"4"}},{"id":1921925,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-12T01:15:57.000Z","date":"2023-04-07","kind":"exercise","planned":false,"acquired":true,"shares":1489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":5720,"source":{"system":"sec-edgar","filing":"0001209191-23-024061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123024061/doc4.xml","form_type":"4"}},{"id":1923196,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-08T00:41:27.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":2009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":6030,"derivative":{"underlying":"Common Stock","underlying_shares":2009},"source":{"system":"sec-edgar","filing":"0001209191-23-023864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023864/doc4.xml","form_type":"4"}},{"id":1923195,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-08T00:41:27.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":701,"price":18.16,"value":12730.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.16 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4231,"source":{"system":"sec-edgar","filing":"0001209191-23-023864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023864/doc4.xml","form_type":"4"}},{"id":1923194,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-08T00:41:27.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":2009,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":4932,"source":{"system":"sec-edgar","filing":"0001209191-23-023864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023864/doc4.xml","form_type":"4"}},{"id":1991080,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-28T02:00:44.000Z","date":"2023-02-23","kind":"exercise","acquired":false,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":1680,"derivative":{"underlying":"Common Stock","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001209191-23-013471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013471/doc4.xml","form_type":"4"}},{"id":1991079,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:44.000Z","date":"2023-02-24","kind":"sale","acquired":false,"shares":350,"price":18.78,"value":6573.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":2923,"source":{"system":"sec-edgar","filing":"0001209191-23-013471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013471/doc4.xml","form_type":"4"}},{"id":1991078,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:44.000Z","date":"2023-02-23","kind":"exercise","acquired":true,"shares":840,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":3273,"source":{"system":"sec-edgar","filing":"0001209191-23-013471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013471/doc4.xml","form_type":"4"}},{"id":2299571,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-12T00:02:21.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":2977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024."}],"balance_after":2978,"derivative":{"underlying":"Common Stock","underlying_shares":2977},"source":{"system":"sec-edgar","filing":"0001209191-22-024064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122024064/doc4.xml","form_type":"4"}},{"id":2299570,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2022-04-12T00:02:21.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":1025,"price":27.05,"value":27726.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":2433,"source":{"system":"sec-edgar","filing":"0001209191-22-024064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122024064/doc4.xml","form_type":"4"}},{"id":2299569,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2022-04-12T00:02:21.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":2977,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."}],"balance_after":3458,"source":{"system":"sec-edgar","filing":"0001209191-22-024064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122024064/doc4.xml","form_type":"4"}},{"id":2301766,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T23:00:50.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":8039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":8039,"derivative":{"underlying":"Common Stock","underlying_shares":8039},"source":{"system":"sec-edgar","filing":"0001209191-22-023743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023743/doc4.xml","form_type":"4"}},{"id":2301765,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-07T23:00:50.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":13793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 5, 2023. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":13793,"derivative":{"exercise_price":25.75,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":13793},"source":{"system":"sec-edgar","filing":"0001209191-22-023743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023743/doc4.xml","form_type":"4"}},{"id":2372886,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:45:58.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":2520,"derivative":{"underlying":"Common Stock","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001209191-22-013286","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013286/doc4.xml","form_type":"4"}},{"id":2372885,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-25T22:45:58.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":359,"price":23.8,"value":8544.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":481,"source":{"system":"sec-edgar","filing":"0001209191-22-013286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013286/doc4.xml","form_type":"4"}},{"id":2372884,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-25T22:45:58.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":840,"source":{"system":"sec-edgar","filing":"0001209191-22-013286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013286/doc4.xml","form_type":"4"}},{"id":2503449,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-11-19T23:36:38.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":15860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":15860,"derivative":{"underlying":"Common Stock","underlying_shares":15860},"source":{"system":"sec-edgar","filing":"0001209191-21-065928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121065928/doc4.xml","form_type":"4"}},{"id":2503448,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-11-19T23:36:38.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":15860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows:  37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows:  37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":15860,"derivative":{"underlying":"Common Stock","underlying_shares":15860},"source":{"system":"sec-edgar","filing":"0001209191-21-065928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121065928/doc4.xml","form_type":"4"}},{"id":2833470,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-26T02:48:16.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":3360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":3360,"derivative":{"underlying":"Common Stock","underlying_shares":3360},"source":{"system":"sec-edgar","filing":"0001209191-21-014560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121014560/doc4.xml","form_type":"4"}},{"id":2833469,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":34940,"kind":"person","name":"Kihara James","position":1,"cik":"0001816160","reported_name":"Kihara James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-26T02:48:16.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":6187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2022. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":6187,"derivative":{"exercise_price":49.74,"expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":6187},"source":{"system":"sec-edgar","filing":"0001209191-21-014560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121014560/doc4.xml","form_type":"4"}}]}